Cell MedX Stock Price, News & Analysis (OTCMKTS:CMXC)

$0.16 -0.03 (-14.19 %)
(As of 02/20/2018 04:00 PM ET)
Previous Close$0.19
Today's Range$0.15 - $0.16
52-Week Range$0.15 - $0.48
Volume3,300 shs
Average Volume6,284 shs
Market Capitalization$7.11 million
P/E Ratio-8.08
Dividend YieldN/A

About Cell MedX (OTCMKTS:CMXC)

Cell MedX Corp. is a development-stage company focused on the discovery, development and commercialization of therapeutic products for patients with diseases, such as diabetes, by developing technologies to help manage the illness and related complications. The Company, through its subsidiary, Avyonce Cosmedics Inc. (Avyonce), is engaged in reselling and marketing spa technology and equipment to the beauty and wellness industry. Avyonce is involved in carrying out observational studies using eBalance Technology. The eBalance Technology is used for the use of micro currents for the treatment of diabetes and related ailments. Avyonce also provides continuing education to the estheticians and healthcare professionals in the field of medical aesthetics. The Company is engaged in developing a family of devices based on the eBalance Technology.

Receive CMXC News and Ratings via Email

Sign-up to receive the latest news and ratings for CMXC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Conglomerates


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio-8.075
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS($0.02)
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on Assets-160.14%


Outstanding Shares44,040,000

Cell MedX (OTCMKTS:CMXC) Frequently Asked Questions

What is Cell MedX's stock symbol?

Cell MedX trades on the OTCMKTS under the ticker symbol "CMXC."

Who are some of Cell MedX's key competitors?

Who are Cell MedX's key executives?

Cell MedX's management team includes the folowing people:

  • Frank Edward McEnulty, President, Director (Age 59)
  • Terrance G. Owen Ph.D., Chief Executive Officer (Age 69)
  • Yanika S. Silina, Chief Financial Officer, Treasurer, Secretary, Director (Age 37)
  • Bradley S. Hargreaves, Vice President - Technology and Operations, Director (Age 56)
  • John Sanderson M.D., Chief Medical Officer (Age 65)

How do I buy Cell MedX stock?

Shares of Cell MedX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cell MedX's stock price today?

One share of Cell MedX stock can currently be purchased for approximately $0.16.

How big of a company is Cell MedX?

Cell MedX has a market capitalization of $7.11 million.

How can I contact Cell MedX?

Cell MedX's mailing address is 123 W Nye Ln Ste 446, CARSON CITY, NV 89706-0899, United States. The company can be reached via phone at +1-310-5089398.

MarketBeat Community Rating for Cell MedX (CMXC)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  31 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  55
MarketBeat's community ratings are surveys of what our community members think about Cell MedX and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cell MedX (OTCMKTS:CMXC) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Earnings History for Cell MedX (OTCMKTS:CMXC)

No earnings announcements for this company have been tracked by MarketBeat.com


Cell MedX (OTCMKTS:CMXC) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for Cell MedX (OTCMKTS:CMXC)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Cell MedX (OTCMKTS CMXC) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Cell MedX (OTCMKTS:CMXC)

Cell MedX (OTCMKTS CMXC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/12/2017Frank McenultyCEOBuy481,016$0.25$120,254.00View SEC Filing  
8/21/2017Richard JeffsMajor ShareholderBuy1,000$0.29$290.002,516,126View SEC Filing  
6/15/2017Richard JeffsMajor ShareholderBuy2,690$0.27$726.302,514,956View SEC Filing  
6/9/2017Richard JeffsMajor ShareholderBuy50,000$0.18$9,000.002,512,266View SEC Filing  
5/11/2017Richard JeffsMajor ShareholderBuy5,000$0.35$1,750.002,462,266View SEC Filing  
5/5/2017Richard JeffsMajor ShareholderBuy12,800$0.43$5,504.002,455,666View SEC Filing  
4/10/2017Richard JeffsMajor ShareholderBuy5,190$0.32$1,660.802,445,666View SEC Filing  
3/23/2017Richard JeffsMajor ShareholderBuy21,560$0.36$7,761.602,428,916View SEC Filing  
3/13/2017Richard JeffsMajor ShareholderBuy9,500$0.27$2,565.002,414,416View SEC Filing  
3/8/2017Richard JeffsMajor ShareholderBuy20,000$0.30$6,000.002,394,416View SEC Filing  
3/1/2017Richard JeffsMajor ShareholderBuy10,000$0.28$2,800.002,389,416View SEC Filing  
2/28/2017Richard JeffsMajor ShareholderBuy18,984$0.26$4,935.842,370,432View SEC Filing  
1/18/2017Richard JeffsMajor ShareholderBuy10,000$0.31$3,100.002,360,432View SEC Filing  
1/10/2017Richard JeffsMajor ShareholderBuy10,000$0.30$3,000.002,350,432View SEC Filing  
1/9/2017Richard JeffsMajor ShareholderBuy58,500$0.28$16,380.002,284,432View SEC Filing  
12/30/2016Richard JeffsMajor ShareholderBuy4,500$0.26$1,170.002,280,432View SEC Filing  
12/23/2016Richard JeffsMajor ShareholderBuy7,500$0.25$1,875.002,272,432View SEC Filing  
12/14/2016Richard JeffsMajor ShareholderBuy100$0.22$22.002,269,932View SEC Filing  
12/6/2016Richard JeffsMajor ShareholderBuy5,000$0.25$1,250.002,269,832View SEC Filing  
12/5/2016Richard JeffsMajor ShareholderBuy21,100$0.23$4,853.002,253,732View SEC Filing  
11/23/2016Richard JeffsMajor ShareholderBuy13,500$0.24$3,240.002,233,732View SEC Filing  
11/15/2016Richard JeffsMajor ShareholderBuy7,500$0.25$1,875.002,223,732View SEC Filing  
11/10/2016Richard JeffsMajor ShareholderBuy17,500$0.26$4,550.002,210,232View SEC Filing  
11/2/2016Richard JeffsMajor ShareholderBuy5,000$0.25$1,250.002,205,232View SEC Filing  
10/14/2016Richard JeffsMajor ShareholderBuy8,000$0.27$2,160.002,200,232View SEC Filing  
10/4/2016Richard JeffsMajor ShareholderBuy10,000$0.22$2,200.002,192,232View SEC Filing  
9/22/2016Richard JeffsMajor ShareholderBuy5,000$0.20$1,000.002,177,262View SEC Filing  
9/14/2016Richard JeffsMajor ShareholderBuy24,332$0.20$4,866.402,167,232View SEC Filing  
8/23/2016Richard JeffsMajor ShareholderBuy10,000$0.15$1,500.002,152,900View SEC Filing  
8/17/2016Richard JeffsMajor ShareholderBuy10,250$0.17$1,742.502,142,900View SEC Filing  
8/16/2016Richard JeffsMajor ShareholderBuy9,750$0.17$1,657.502,130,650View SEC Filing  
(Data available from 1/1/2013 forward)


Cell MedX (OTCMKTS CMXC) News Headlines


SEC Filings

Cell MedX (OTCMKTS:CMXC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Cell MedX (OTCMKTS CMXC) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.